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Abstract
Objectives Multimodal non-invasive imaging plays a key role
in establishing a diagnosis of PHVendocarditis. The objective
of this study was to provide a systematic review of the litera-
ture and meta-analysis of the diagnostic accuracy of TTE,
TEE, and MDCT in patients with (suspected) PHV
endocarditis.
Methods Studies published between 1985 and 2013 were
identified via search and cross-reference of PubMed/Embase
databases. Studies were included if (1) they reported on the
non-invasive index tests TTE, TEE, or MDCT; (2) data was
provided on PHVendocarditis as the condition of interest; and
(3) imaging results were verified against either surgical
inspection/autopsy or clinical follow-up reference standards,
thereby enabling the extraction of 2-by-2 tables.
Results Twenty articles (including 496 patients) met the inclu-
sion criteria for PHV endocarditis. TTE, TEE, and MDCT+
TEE had a pooled sensitivity/specificity for vegetations of 29/
100 %; 82/95 %, and 88/94 %, respectively. The pooled
sensitivity/specificity of TTE, TEE, and MDCT+TEE for
periannular complications was 36/93 %, 86/98 %, and 100/
94 %, respectively.
Conclusions TEE showed good sensitivity and specificity for
establishing a diagnosis of PHV endocarditis. Although
MDCT data are limited, this review showed that MDCT in
addition to TEE may improve sensitivity in detecting life-
threatening periannular complications.
Key Points
• Multimodal imaging is an important ingredient of diagnos-
tic workup for PHVendocarditis.
• Transthoracic and transesophageal echography may miss
life-threatening periannular complications.
• MDCT can improve sensitivity for the detection of life-
threatening periannular complications.
Keywords Echocardiography . Computed tomography .
Endocarditis . Prosthetic heart valve . Systematic review
Introduction
Left-sided native heart valve disease often requires prosthetic
heart valve (PHV) implantation, especially in the aortic posi-
tion. In 2003, approximately 290,000 patients worldwide
Jesse Habets and Wilco Tanis contributed equally to this work.
Electronic supplementary material The online version of this article
(doi:10.1007/s00330-015-3605-7) contains supplementary material,
which is available to authorized users.
J. Habets (*) :W. P. T. M. Mali
Department of Radiology, University Medical Center Utrecht,
Heidelberglaan 100, 3508 GA Utrecht, The Netherlands
e-mail: J.Habets@umcutrecht.nl
W. Tanis
Department of Cardiology, Haga Teaching Hospital, The Hague, The
Netherlands
J. B. Reitsma
Julius Center for Health Sciences and Primary Care, University
Medical Center Utrecht, Utrecht, The Netherlands
R. B. A. van den Brink
Department of Cardiology, Academic Medical Center,
Amsterdam, The Netherlands
S. A. J. Chamuleau
Department of Cardiology, University Medical Center Utrecht,
Utrecht, The Netherlands
R. P. J. Budde
Department of Radiology, Erasmus Medical Center, Rotterdam, The
Netherlands
Eur Radiol (2015) 25:2125–2133
DOI 10.1007/s00330-015-3605-7
underwent heart valve replacement, and this figure is expected
to rise, largely as a result of the ageing population, reaching an
annual incidence of 850,000 by 2050 [1]. Although PHV im-
plantation is a lifesaving surgical procedure, its major draw-
back is the risk of complications such as PHVobstruction or
PHV endocarditis. PHV endocarditis is a life-threatening dis-
ease, with an incidence of 0.3–1.2 % per patient-year, and is
associated with high rates of mortality and comorbidity as
well as substantial health care costs [2].
In clinical practice, PHV endocarditis presents with a
heterogeneous spectrum of clinical manifestations such as
fever, heart failure symptoms, or systematic embolization.
According to the modified Duke criteria, echocardiogra-
phy plays a pivotal role in establishing a diagnosis of
PHV endocarditis [3]. TTE is the first-line clinical screen-
ing tool for the detection of PHV endocarditis, but often
fails to detect positive signs of the disease such as vege-
tations and periannular complications (abscesses/mycotic
aneurysms). TEE can add incremental value to TTE, but
may still fail to detect life-threatening signs of PHV en-
docarditis. Multidetector-row computed tomography
(MDCT) has recently emerged as a promising novel im-
aging technique for evaluating PHVs, and may provide
complementary diagnostic information to echocardiogra-
phy in patients with suspected PHV endocarditis [4].
The purpose of this systematic review was to compare the
diagnostic accuracy of transthoracic echocardiography (TTE),
t ransoesophagea l echocard iography (TEE) , and
multidetector-row computed tomography (MDCT) plus TEE
in patients with (suspected) PHVendocarditis.
Material and methods
Literature search
A systematic electronic search was performed in the PubMed
and Embase databases for original works published through
July 23, 2013. Articles were restricted to English language
publications, and studies published before 1985 were exclud-
ed. Key search terms included the non-invasive imaging mo-
dalities TTE, TEE, and MDCT, and prosthetic heart valves
and corresponding synonyms (Appendix I). Cross-
referencing was performed for all full-text papers included.
Selection of publications
After duplicates were removed, the titles and abstracts were
independently screened by two reviewers (JH and WT). Arti-
cles were included if they met three inclusion criteria. 1) The
studies reported on one of the following non-invasive index
tests: transthoracic echocardiogram (TTE), transesophageal
echocardiogram (TEE), or retrospectively ECG-gated or
prospectively ECG-triggered multidetector-row computed to-
mography (MDCT). 2) They provided data on PHVendocar-
ditis as the condition of interest. 3) Imaging results were ver-
ified against the reference standard of surgical inspection/
autopsy or clinical follow-up, thereby enabling the extraction
of 2-by-2 tables. Full-text publications of the included articles
were obtained and were assessed independently by the two
reviewers, and publications and data extraction were then ex-
tensively discussed in a consensus meeting.
Quality assessment
Information was collected on patient populations, study enrol-
ment, non-invasive imaging modalities, and reference stan-
dard. Studies were systematically assessed for quality based
on the validated Quality Assessment of Diagnostic Accuracy
Studies (QUADAS)-2 checklist [5], which assesses the risk of
bias and clinical applicability of studies based on four key
domains: patient selection, index test, reference standard,
and flow and timing.
Data analysis
The diagnostic accuracy of the different imaging modalities
was assessed for the detection of the following signs of PHV
endocarditis: vegetations, periannular complications (abscess-
es, mycotic aneurysms/pseudoaneurysms), PHV dehiscence,
and PHVendocarditis in general. These signs of interest were
defined according to echocardiographic criteria as follows: 1)
vegetations, defined as irregularly shaped oscillating masses
adherent to and distinct from the myocardium; 2) abscesses,
defined as irregularly shaped inhomogeneous paravalvular
enclosed masses within the periannular region, myocardium,
or pericardium; 3) mycotic aneurysms/pseudoaneurysms, de-
fined as echo-free perivalvular cavities with flow communi-
cating with the cardiovascular lumen; and 4) PHV dehiscence,
defined as a rockingmotion of a PHV [2, 6]. PHVendocarditis
in general included one or more of the above-mentioned signs
of PHVendocarditis.
Forest plots of sensitivity and specificity were generated,
along with their corresponding 95 % confidence intervals
(CI), and were stratified by target conditions and data within
each forest plot grouped by index test (TTE, TEE, orMDCT+
TEE). The bivariate random effects model was used to com-
pare summary estimates of sensitivity and specificity for each
of the index tests. The bivariate approach simultaneously
models pairs of (logit-transformed) sensitivity and specificity
from studies, thereby incorporating any correlation that might
exist between sensitivity and specificity. The model uses a
random effects approach for both sensitivity and specificity,
allowing for heterogeneity beyond chance due to clinical and
methodological differences among studies. In the event that
the results displayed no variation beyond that expected by
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chance, models were simplified to fixed-effects pooling of
sensitivity, specificity, or both. To compare index tests, we
extended the bivariate model with a covariate indicating the
type of index test. Such a model calculates different summary
estimates for sensitivity and specificity for each index test and
also provides a formal test to determine whether differences
are statistically different. The non-linear mixed models proce-
dure (PROC NLMIXED) in SAS 9.2 (SAS Institute, Cary,
NC, USA) was used to estimate the parameters of the bivariate
models. P values less than 0.05 were considered statistically
significant.
Results
Search results
The systematic electronic search yielded a total of 89 publica-
tions after screening of titles and abstracts. Sixty full-text ver-
sions of the studies were obtained, and 45 studies were
excluded for various reasons (Fig. 1). Cross-referencing of
all included full-text articles resulted in six additional articles,
and our recently accepted paper was added for completeness
[7]. The final selection of articles included 22 studies for sys-
tematic review. Two studies reporting on PHV endocarditis
were excluded because no diagnostic accuracy data were
available [8, 9]; therefore, 20 studies were ultimately included
in the meta-analysis.
PHVendocarditis
Twenty-two studies reporting on the echocardiographic (TTE/
TEE) detection of signs of endocarditis using were included in
the systematic review (Table 1) [7–27]. Three studies reported
on retrospectively ECG-gated MDCT findings [7, 10, 28].
Data were prospectively (dedicated data collection; n=11;
50 %) and retrospectively (routine care data; n=11; 50 %)
collected (Table 1). In 15 (68 %) studies, the inclusion period
occurred completely or partially in 1990 or earlier. The refer-
ence standard was exclusively surgical inspection or autopsy
Fig. 1 Systematic literature
search
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in 14 (64 %) studies. In eight studies (36 %), clinical criteria
and/or follow-up were mentioned as the reference standard.
Less than half of the studies (n=8, 36 %) included multiplanar
TEE assessment. Themajority of studies (n=14, 64%) did not
report on the interval between the index and reference tests.
Two studies had a long time interval (>2 weeks) between
index test and reference standard [14, 22]. The other six stud-
ies (27 %) had an acceptable time interval (≤2 weeks) [7, 10,
13, 16, 21, 27]. Assessment of the index test was blinded
(without knowledge of the reference standard) in 15 (68 %)
studies. In six of the 22 studies (27 %), it was unclear whether
assessment was blinded, and one study included no blinding
[19]. The same reference standard was used for all patients in
17 (77 %) studies. In 12 (54 %) studies, all patients were
included in the data analyses. In the meta-analysis, the previ-
ously mentioned signs of PHV endocarditis were analysed.
Diagnostic accuracy measures for the detection of signs of
PHV endocarditis were able to be extracted in 20 studies
(n=473 patients) (Table 1).
Vegetations
Figures 2 and 3 present the sensitivity and specificity of TTE
(n=63), TEE (n=113), and MDCT+TEE (n=50) for the de-
tection of vegetations. The pooled TTE sensitivity and speci-
ficity for the detection of vegetations were 29% [95%CI: 9–6
2 %] and 100 % [95 % CI: 86–100 %], respectively. TEE
(82 % [95 % CI: 69–90 %]) and MDCT+TEE (88 % [95 %
CI: 61–97 %] were more sensitive than TTE (both p<0.01).
No significant difference was found between TEE and TEE+
MDCT (p=0.60), and there were no significant differences in
specificity between TTE and TEE/MDCT+TEE (96 % [9 5%
CI: 81–99%] and 94% [95 % CI: 81–98%], respectively; p=
0.12).
Periannular complications
The sensitivity and specificity of TTE (n=172), TEE (n=412),
and MDCT+TEE (n=58) for the detection of periannular
complications are presented in Figs. 2 and 3. The pooled
TTE sensitivity and specificity for the detection of periannular
complications were 36% [95%CI: 27–46%] and 93% [95%
CI: 84–97 %], respectively. One study reported three false-
positive (43 %) TTE examinations [10]. TEE (86 % [95 %
CI: 81––90 %]) and MDCT+TEE (100 % [95 % CI: 51–
100%]) were more sensitive than TTE (p≤0.03). In one study,
TEE failed to detect 5 of 14 (36 %) periannular complications
in patients with aortic PHV endocarditis [14]. No significant
difference was found between TEE and TEE+MDCT (p=
0.18). There were no significant differences in specificity be-
tween TTE and TEE (98 % [95 % CI: 95–99 %]; p=0.07)
(Fig. 3).
PHV dehiscence
The pooled sensitivity and specificity of TTE (n=18) for the
detection of PHV dehiscence were 11 % [95 % CI: 1–73 %]
and 100 % [95 % CI: 72–100 %], respectively. No significant
difference in sensitivity or specificity was found between TTE
and TEE (n=60) (sensitivity of 94 % [95 % CI: 37––100 %]
and specificity of 97 % [95 % CI: 84–99 %]) (p≥0.05). One
study reported on the detection of PHV dehiscence with
MDCT (n=16) [28]. Fagman et al. [28] reported that seven
cases of PHV dehiscence were detected by both TEE and
MDCT, although TEE detected three additional cases.
General signs of PHVendocarditis
The pooled sensitivity and specificity of TTE (n=55) for the
detection of general signs of PHV endocarditis were 33 %
[95 % CI: 24–42 %] and 100 % [95 % CI: 76–100 %], respec-
tively. TEE (n=114) was more sensitive (86 % [95 % CI: 77–
92 %]) than TTE (p<0.001). No significant differences in
specificity were found between TTE and TEE (95 % [95 %
CI: 82–99 %]) (p=0.29). Only one study (n=28) reported on
the detection of general signs of endocarditis byMDCT [7]. In
this study, the sensitivity of MDCT+TEE (100 %) was higher
than that of TEE (95 %) alone.
Discussion
We systematically reviewed the literature regarding the use of
TTE, TEE, and MDCT for the detection of signs of PHV
endocarditis. Notwithstanding the limited number of studies
reporting on the diagnostic accuracy of these imaging modal-
ities, non-invasive imaging plays a key role in establishing a
diagnosis of PHVendocarditis and has important clinical im-
plications for patient management and outcome. A primary
finding in our analysis was that TEE was more sensitive than
TTE for the detection of both vegetations and periannular
complications, although TEE still failed to detect life-
threatening periannular extensions and vegetations, chiefly
in patients with mechanical aortic PHVs (Fig. 4). The addition
of retrospectively ECG-gated MDCT to TEE can improve the
detection of these periannular extensions and vegetations, pri-
marily in patients with mechanical aortic PHVs. However,
limited data are available at the moment, resulting in broad
confidence intervals.
According to the QUADAS-2 assessment, several stud-
ies were identified as having a risk of bias and/or clinical
applicability concerns. This included patient selection
(only patients who underwent reoperation), older studies
(including monoplanar TEE assessment), unreported
blinding for the reference standard, and interval between
index test and reference standard (Table 1).
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In clinical practice, PHV endocarditis remains a difficult
diagnosis to establish, and is based on the modified Duke
criteria [3]. For the fulfilment of these criteria, one of the
two important major criteria is a positive echocardiogram,
defined as the presence of a vegetation, abscess, PHV dehis-
cence, or new (para)valvular regurgitation. PHV endocarditis
differs from native valve endocarditis in that it presents more
often with periannular extension [29] (53–55 % of cases). In
contrast to native valve endocarditis, blood cultures in PHV
endocarditis are often negative (23–37%), likely due to earlier
administration of antibiotics, and imaging by echocardiogra-
phy is hampered by acoustic shadowing of the PHV [11, 13,
25]. Furthermore, the rate of 6-month mortality for patients
with PHV endocarditis is higher in those with a periannular
extension than in those without periannular complications
(30% vs. 8%, respectively) [16].With Staphylococcus aureus
as the causative microorganism, the mortality rate may further
increase to 54 % [16]. Other relevant independent predictors
of early mortality are patient age, renal failure, and the pres-
ence of an atrioventricular block [11, 13, 16, 25, 30].
The detection of life-threatening abscess formation and
mycotic aneurysms with non-invasive imaging is crucial for
timely surgical intervention, which can improve the clinical
outcome [31]. In this meta-analysis, TEE showed good sensi-
tivity (86 %), and because of its better spatial resolution and
the close relationship between the TEE probe and the heart, it
was proven to be superior to TTE (36 %) for the detection of
abscesses and mycotic aneurysms. Despite this higher level of
performance, however, TEE still failed to detect approximate-
ly 15 % of the life-threatening abscesses and mycotic aneu-
rysms that were present. These missed periannular extensions
were primarily located at the anterior side of the aortic root,
which is obscured by acoustic shadowing [13, 16, 21, 27]. In
some cases, TTE can offer additional diagnostic value for the
detection of anteriorly located abscesses, as assessment of this
region is not hampered by acoustic shadowing [27]. In clinical
Fig. 2 Pooled sensitivity analysis
of all studies for vegetations and
periannular extensions
Fig. 3 Pooled specificity analysis
of all studies for vegetations and
periannular extensions
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practice, failure to detect periannular complications of PHV
endocarditis is unacceptable, and in this context, complemen-
tary non-invasive imaging is required. Additional non-
invasive imaging may also be valuable for reducing the num-
ber of false-positives (2–7 %) with echocardiography as a
means to reduce the risk of unwarranted exposure to a repeat
surgery.
This meta-analysis demonstrated that MDCT can provide
additional relevant diagnostic information in this high-risk
patient group, and should be considered as a complementary
imaging technique in routine clinical workup (TTE/TEE), es-
pecially in patients with suspected aortic PHVendocarditis. In
addition to MDCT, other imaging tools (3D TEE and FDG-
PET/CT) may also improve the detection of periannular ex-
tension. To date, no prospective studies have been published
on the diagnostic value of 3D TEE for detection of periannular
complications in patients with PHV endocarditis. This tech-
nique could be especially valuable in patients with contrain-
dications for MDCT evaluation because of renal impairment.
Saby et al. [32] recently prospectively studied the diagnostic
accuracy of FDG-PET/CT in PHV endocarditis and assessed
the complementary value of PET/CT as a major criterion of
the modified Duke criteria in a study of 72 patients with
suspected PHV endocarditis. The reference standard was de-
fined as 3 months of clinical follow-up (82 % of cases) and/or
pathological modified Duke criteria (18 % of cases). The sen-
sitivity and specificity of FDG-PET for PHVendocarditis was
73 % and 80 %, respectively. When FDG-PETwas added as a
new major criterion to the modified Duke criteria, the sensi-
tivity rose from 70% to 97%. This add-on value of FDG-PET
is more or less comparable to the complementary value of
MDCT to echocardiography found in our meta-analysis.
Moreover, the results of the study by Saby et al. [32] demon-
strated that PET/CT missed vegetations in 9/20 (45 %) cases
where there were no other signs of PHV endocarditis. The
authors mentioned in the discussion that the spatial resolution
of FDG-PET/CT was inferior in comparison to TEE. The
present meta-analysis shows that the addition of MDCT to
TEE may improve sensitivity not only for the detection of
periannular extensions, but for vegetations as well. Despite
its inferior spatial resolution compared to TEE and MDCT,
FDG-PET/CT provides additional metabolic information that
can be of value in discerning the presence of active inflamma-
tion. However, no reference values exist for FDG uptake
Fig. 4 Complementary value of
MDCT+TEE. In this patient with
a Carbomedics bileaflet PHV in
the aortic position, TTE
demonstrated severe aortic
regurgitation. In addition, TEE
and MDCT revealed a mycotic
aortic root aneurysm directly
below the right coronary artery
(RCA) origin (a, c), with diastolic
paravalvular leakage as seen on
colour Doppler imaging (b).
While acoustic shadowing on the
TEE images (a) hampered
complete and accurate assessment
of the PHV, MDCT showed no
vegetations (c). MDCT nicely
demonstrated the close
relationship between the mycotic
aneurysm and the RCA (c, d).
The location of the mycotic
aneurysm is indicated by an
asterisk on the schematic drawing
(d). (Reprinted with permission
[35])
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around PHVs, and therefore specificity is a concern [33]. In
addition to signs of PHVendocarditis, FDG-PET-CT can also
detect extracardiac infectious foci that may be relevant for
patient management (e.g., splenic abscess). Thus, combined
contrast-enhanced MDCT and FDG-PET has also been sug-
gested for determining treatment strategy [34]. More prospec-
tive studies are needed in order to determine the exact value
and position in the diagnostic algorithm of the above-
mentioned additional diagnostic modalities. PET-CT was not
added as imaging modality to our meta-analysis because only
one prospective paper [32] was available at the time of the
structured search.
Limitations
This systematic review and meta-analysis had certain limita-
tions. Firstly, in the majority of studies, a selected population
was examined—namely, a surgically explored group— and
therefore the data provided in this meta-analysis cannot sim-
ply be extrapolated to individual patients with suspicion of
PHV endocarditis. Furthermore, patients with negative imag-
ing findings will often not undergo reoperation; consequently,
this specific patient category was not included in the data
analysis in many studies. This paper advocates for more pro-
spective diagnostic cross-sectional studies to determine the
exact value of novel non-invasive imaging modalities (3D
TEE, MDCT, and FDG-PET/CT) in patients with suspected
PHV endocarditis. Secondly, the exact location of missed
periannular complications and the sort of TEE probe used
(mono/bi/multiplane) was not provided inmany of the studies,
and so meta-regression could not be performed for these co-
variates. Thirdly, in a considerable number of the studies, the
interval of time between index test and reference standard was
either not reported or was too long. This time interval is a
critical factor in determining the reliability of diagnostic accu-
racy measures. In addition, limitedMDCT data were available
(n=50), resulting in large confidence intervals for the pooled
estimates of MDCT+TEE. Prospective MDCT studies are
needed to confirm the promising findings of this meta-
analysis.
Fourth, in clinical practice, MDCT studies have demon-
strated that MDCT can have additional diagnostic value,
chiefly in patients with mechanical aortic PHVs. We were
not able to perform meta-regression analysis on valve position
(aortic vs. mitral position), as this data could not be extracted
from the majority of studies and because of the small patient
numbers in the limited MDCT data that was available.
Conclusions
TEE demonstrates good sensitivity and specificity for estab-
lishing a diagnosis of PHV endocarditis and for detecting
complications associated with highmortality, yet it still misses
a substantial number of signs of PHVendocarditis. MDCT in
addition to echocardiography may improve diagnostic accu-
racy in patients with suspected PHVendocarditis, especially in
cases of life-threatening periannular extensions requiring ur-
gent reoperation. Further prospective studies are needed to
determine the diagnostic value and position in the diagnostic
algorithm of additional novel 3D TEE, MDCT, and FDG-
PET/CT imaging modalities.
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